Johnson & Johnson ACUVUE Theravision with Ketotifen (etafilcon A drug-eluting contact lens with ketotifen)

Nazione: Singapore

Lingua: inglese

Fonte: HSA (Health Sciences Authority)

Commercializzato da:

Johnson & Johnson International (Singapore) Pte Ltd

Classe:

Class D (contains therapeutic product or medicinal product)

Prodotto da:

Johnson & Johnson Vision Care, Inc.

Area terapeutica:

Ophthalmology

Indicazioni terapeutiche:

ACUVUE Theravision with Ketotifen are daily wear, daily disposable drug-eluting contact lenses containing an antihistamine to prevent ocular itch due to allergic conjunctivitis and correction of refractive ametropia (myopia and hyperopia) in patients who do not have red eye(s), are suitable for contact lens wear and do not have more than 1.00 D of astigmatism. Itchy eye prevention has been demonstrated to last up to 12 hours in clinical trials; however, the lens may be worn for longer than 12 hours for vision correction.

Dettagli prodotto:

Device System Info:[Sterile Medical Device], Terminally sterilized using the method of steam over pressure; Models: ACUVUE Theravision with Ketotifen (SPH: -12.00D to +6.00D) (Pack size: 1, 2, 3, 5, 6, 10, 12, 20, 24, 30, 60, 90, 180, 360 lenses) (Trial size: 5 lenses) - ACUVUE Theravision with Ketotifen Contact Lenses

Data dell'autorizzazione:

2022-12-19